Variant "ATP7B:c.845G>A(p.Cys282Tyr)"
Search result: 1 record
Variant information
Gene:
Variant:
ATP7B:c.845G>A(p.Cys282Tyr) 
dbSNP ID:
no data 
GWAS trait:
no data 
Modifier statisitcs
Record:
Disorder:
Reference:
Effect type:
Expressivity(1)  
Modifier effect:
Altered expression of iron overload(1)  
Detail:
  • Target disease:
    Wilson Disease (DOID_893)
    Effect type:
    Expressivity 
    Modifier effect:
    Altered expression of iron overload 
    Evidence:
    From review article 
    Effect:
    The A1-ATZ mutation is generally required for the development of liver disease in A1-AT although there is increasing evidence for modifier effects from a heterozygous genotype in other liver diseases.
    Reference:
    Title:
    Genetic modifiers of liver injury in hereditary liver disease.
    Species studied:
    Human
    Abstract:
    The genetic background of patients with liver diseases modulates hepatic injury, with some individuals being predisposed to better defenses and regenerative capacity. In this review, we focus our description of this phenomenon on inherited disorders affecting the liver, with a particular emphasis on Wilson disease (WD), genetic hemochromatosis, and α-1 anti-trypsin disease (A1-AT). Wide variations in the clinical phenotype of WD may in part be related to the mutations of the ATP7B genotype, though modifier genes and environmental factors also likely play an important role. There is also a significant variability in the expression of iron overload in patients with genetic hemochromatosis that are homozygous for the C282Y mutation. Homozygosity for the A1-ATZ mutation is generally required for the development of liver disease in A1-AT although there is increasing evidence for modifier effects from a heterozygous genotype in other liver diseases.